PharmaResearch has made its first entry into the gynecology market, focusing on women's health.
On August 4, the company announced that it showcased its inaugural gynecological product, 'Gyner,' at the Summer Academic Conference of the Korean Society of Women's Sexual Medicine, held on July 26 at the Plenty Convention Center in Seoul.
The Korean Society of Women's Sexual Medicine is an academic organization dedicated to improving women's quality of life and advancing the field of women's sexual health through the sharing of the latest research and clinical experiences. Approximately 200 gynecologists attended the conference, where PharmaResearch introduced the clinical utility and product capabilities of Gyner, a Class II wound dressing made with its proprietary ingredient, 'DOT® PN.'
Gyner is a transparent adhesive wound dressing designed for use on sensitive areas prone to minor bleeding or exudate, such as the female perineum. It aids in the recovery of perineal wounds caused by vaginal dryness and protects the skin from external irritants, supporting hygienic management.
Last month, PharmaResearch held the '2nd A.R.I.A Leaders Forum' to discuss clinical applications and utilization strategies for Gyner. A company representative stated, "With the launch of Gyner, we aim to accumulate clinical data and market insights to strengthen our position in the gynecology sector."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.